acebutolol has been researched along with Kidney Diseases in 5 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 6.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "During 10 years of clinical use involving almost 3 million patient-years, acebutolol has become established as a remarkably safe and well-tolerated beta-blocking agent, effective in treating essential hypertension and cardiac arrhythmias." | 4.77 | Acebutolol: ten years of experience. ( De Bono, G; Kaye, CM; Roland, E; Summers, AJ, 1985) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 2.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol has a major non-renal route of elimination, but the acetyl metabolite (also a beta-adrenoreceptor blocking drug) is primarily excreted by the kidney and may accumulate in renal failure." | 1.26 | Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment. ( Bailey, RR; Begg, E; Ebert, R; Ferry, DG; Munn, S, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munn, S | 1 |
| Bailey, RR | 1 |
| Begg, E | 1 |
| Ebert, R | 1 |
| Ferry, DG | 1 |
| Kirch, W | 1 |
| Köhler, H | 1 |
| Berggren, G | 1 |
| Braun, W | 1 |
| De Bono, G | 1 |
| Kaye, CM | 1 |
| Roland, E | 1 |
| Summers, AJ | 1 |
| Loirat, C | 1 |
| Singh, BN | 1 |
| Thoden, WR | 1 |
| Ward, A | 1 |
3 reviews available for acebutolol and Kidney Diseases
| Article | Year |
|---|---|
Acebutolol: ten years of experience.
Topics: Acebutolol; Adrenergic beta-Antagonists; Age Factors; Animals; Arrhythmias, Cardiac; Blood Circulati | 1985 |
[Arterial hypertension in the newborn infant. Etiologies. Treatment].
Topics: Acebutolol; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Endoc | 1988 |
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Topics: Acebutolol; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Vessels; B | 1985 |
2 other studies available for acebutolol and Kidney Diseases
| Article | Year |
|---|---|
Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; | 1980 |
The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Topics: Acebutolol; Administration, Oral; Adolescent; Adult; Aged; Female; Glomerular Filtration Rate; Half- | 1982 |